CD79a and CD79b form the heterodimeric signaling component of the B-cell receptor, with CD79b being nearly universally expressed in mature B-cell lymphomas and normal B cells (60). The gene discussed is CD79A; the disease is B-cell non-Hodgkin lymphoma.